Schellekens H - Search Results

1

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice.

Filipe V, Jiskoot W, Basmeleh AH, Halim A, Schellekens H, Brinks V. Filipe V, et al. Among authors: schellekens h. MAbs. 2012 Nov-Dec;4(6):740-52. doi: 10.4161/mabs.22066. Epub 2012 Sep 5. MAbs. 2012. PMID: 22951518 Free PMC article.

2

Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.

van Beers MM, Sauerborn M, Gilli F, Brinks V, Schellekens H, Jiskoot W. van Beers MM, et al. Among authors: schellekens h. Pharm Res. 2011 Oct;28(10):2393-402. doi: 10.1007/s11095-011-0451-4. Epub 2011 May 5. Pharm Res. 2011. PMID: 21544687 Free PMC article.

3

Effect of treatment regimen on the immunogenicity of human interferon Beta in immune tolerant mice.

Kijanka G, Jiskoot W, Schellekens H, Brinks V. Kijanka G, et al. Among authors: schellekens h. Pharm Res. 2013 Jun;30(6):1553-60. doi: 10.1007/s11095-013-0992-9. Epub 2013 Jan 30. Pharm Res. 2013. PMID: 23361590

4

Development of a transgenic mouse model to study the immunogenicity of recombinant human insulin.

Torosantucci R, Brinks V, Kijanka G, Halim LA, Sauerborn M, Schellekens H, Jiskoot W. Torosantucci R, et al. Among authors: schellekens h. J Pharm Sci. 2014 May;103(5):1367-74. doi: 10.1002/jps.23935. Epub 2014 Mar 11. J Pharm Sci. 2014. PMID: 24619587

5

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

van Beers MM, Sauerborn M, Gilli F, Brinks V, Schellekens H, Jiskoot W. van Beers MM, et al. Among authors: schellekens h. Pharm Res. 2010 Sep;27(9):1812-24. doi: 10.1007/s11095-010-0172-0. Epub 2010 May 25. Pharm Res. 2010. PMID: 20499141 Free PMC article.

6

Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene.

Van Beers MM, Gilli F, Schellekens H, Randolph TW, Jiskoot W. Van Beers MM, et al. Among authors: schellekens h. J Pharm Sci. 2012 Jan;101(1):187-99. doi: 10.1002/jps.22744. Epub 2011 Sep 14. J Pharm Sci. 2012. PMID: 21918983

7

Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.

Sauerborn M, van Beers MM, Jiskoot W, Kijanka GM, Boon L, Schellekens H, Brinks V. Sauerborn M, et al. Among authors: schellekens h. J Clin Immunol. 2013 Jan;33(1):255-63. doi: 10.1007/s10875-012-9783-z. Epub 2012 Sep 4. J Clin Immunol. 2013. PMID: 22945588

8

The immunogenicity of polyethylene glycol: facts and fiction.

Schellekens H, Hennink WE, Brinks V. Schellekens H, et al. Pharm Res. 2013 Jul;30(7):1729-34. doi: 10.1007/s11095-013-1067-7. Epub 2013 May 15. Pharm Res. 2013. PMID: 23673554 Review.

9

Immunogenicity of mAbs in non-human primates during nonclinical safety assessment.

van Meer PJ, Kooijman M, Brinks V, Gispen-de Wied CC, Silva-Lima B, Moors EH, Schellekens H. van Meer PJ, et al. Among authors: schellekens h. MAbs. 2013 Sep-Oct;5(5):810-6. doi: 10.4161/mabs.25234. Epub 2013 Jun 6. MAbs. 2013. PMID: 23924803 Free PMC article.

10

A modified immune tolerant mouse model to study the immunogenicity of recombinant human interferon beta.

Abdolvahab MH, Brinks V, Schellekens H. Abdolvahab MH, et al. Among authors: schellekens h. J Immunol Methods. 2014 Dec 15;415:17-23. doi: 10.1016/j.jim.2014.10.004. Epub 2014 Oct 18. J Immunol Methods. 2014. PMID: 25450255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters